Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fortress Biotech, Inc. | Chief Financial Officer | Common Stock, par value $0.001 | 241K | $296K | $1.23 | Oct 1, 2024 | Direct |
AVENUE THERAPEUTICS, INC. | Interim PFO and COO | COMMON STOCK, PAR VALUE $0.0001 | 65K | $9.1K | $0.14 | Sep 23, 2024 | Direct |
Fortress Biotech, Inc. | Chief Financial Officer | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 500 | $4.67K | $9.34 | Jul 10, 2024 | Direct |
MUSTANG BIO, INC. | Director | Common Stock | 1.99K | $698 | $0.35 | Oct 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MBIO | MUSTANG BIO, INC. | Oct 23, 2024 | 0 | $0 | 3 | Oct 29, 2024 | Director |
FBIO | Fortress Biotech, Inc. | Oct 1, 2024 | 1 | $3.22K | 4 | Oct 1, 2024 | Chief Financial Officer |
ATXI | AVENUE THERAPEUTICS, INC. | Sep 23, 2024 | 1 | $0 | 4 | Sep 25, 2024 | Interim PFO and COO |
FBIO | Fortress Biotech, Inc. | Jul 10, 2024 | 1 | $3.75K | 4 | Jul 12, 2024 | Chief Financial Officer |
FBIO | Fortress Biotech, Inc. | Apr 1, 2024 | 1 | $4K | 4 | Apr 2, 2024 | Chief Financial Officer |
FBIO | Fortress Biotech, Inc. | Dec 20, 2023 | 1 | $0 | 4 | Dec 22, 2023 | Chief Financial Officer |
ATXI | AVENUE THERAPEUTICS, INC. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Interim PFO and COO |
FBIO | Fortress Biotech, Inc. | Feb 10, 2023 | 1 | $30K | 4 | Feb 14, 2023 | Chief Financial Officer |
FBIO | Fortress Biotech, Inc. | Nov 30, 2022 | 1 | $2.8K | 4 | Dec 2, 2022 | Chief Financial Officer |
FBIO | Fortress Biotech, Inc. | Oct 26, 2022 | 1 | $0 | 4 | Oct 28, 2022 | Chief Financial Officer |
FBIO | Fortress Biotech, Inc. | Aug 16, 2022 | 0 | $0 | 3 | Aug 25, 2022 | Chief Financial Officer |
ATXI | AVENUE THERAPEUTICS, INC. | May 11, 2022 | 0 | $0 | 3 | May 25, 2022 | Int. PEO, Int. PFO, and COO |